Elsevier

Thrombosis Research

Volume 130, Issue 4, October 2012, Pages 690-691
Thrombosis Research

Letter to the Editors-in-Chief
Improved point-of-care identification of hyperfibrinolysis is needed☆

https://doi.org/10.1016/j.thromres.2012.08.291Get rights and content

Section snippets

Disclosure of Conflicts of Interests

The presented data are based on experiments for which Tem International, Munich, Germany, delivered reagents and consumables free of charge. However, Tem International had no involvement in the study. BS has participated in advisory committees and/or received speaker's bureau from Novo Nordisk, Baxter, CSL Behring, Bayer, SOBI, and TEM International. The Haemostasis Research Unit has received unrestricted research support from TEM International, Novo Nordisk, Baxter, CSL Behring, Bayer, SOBI,

Acknowledgements

The authors would like to thank research technician Kirsten Christiansen for highly qualified assistance.

References (9)

  • D. Frith et al.

    The acute coagulopathy of trauma shock: Clinical relevance

    Surgeon

    (2010)
  • H. Schochl et al.

    Hyperfibrinolysis after major trauma: Differential diagnosis of lysis patterns and prognostic value of thrombelastometry

    J Trauma

    (2009)
  • H. Shakur et al.

    Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial

    Lancet

    (2010)
  • I. Roberts et al.

    The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial

    Lancet

    (2011)
There are more references available in the full text version of this article.
☆

Attribution of the work: Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark.

View full text
Copyright © 2012 Elsevier Ltd. All rights reserved.